Frank Gillen

PreCheck Health Services, Inc. has recently changed its business plan and is commencing operations for the U.S. distribution of a medical screening device, the PC8B, which it purchases from a domestic supplier. The PC8B medical device is a screening tool for use by physicians in managing a patient's health. The mathematical analysis of body signals provides markers of cardio metabolic risk, autonomic neuropathy and vascular dysfunction. The PC8B markers and scoring system are clinically validated and patented by the manufacturer. The system is non-invasive and combined with a fast ankle brachial index test, which is a quick noninvasive way to check for peripheral artery disease, takes less than 8 minutes. Depending on the risk score for each factor, the physician will be able to advise the patient with respect to the patient'??s condition as reflected by the test results. The tests which the PC8B performs are generally covered and reimbursed by Medicare, Medicaid and most insurance companies. The company was founded on March 19, 2014 and is headquartered in Miami, FL.